247102-02-9

Basic information

• Product Name: N-(benzoyl)-N'-(3-carboxy-5-pyridinyl)thiourea
• Synonyms: N-(benzoyl)-N'-(3-carboxy-5-pyridinyl)thiourea
• CAS NO: 247102-02-9
• Molecular Weight: 301.326
• Mol File: 247102-02-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: N-(benzoyl)-N'-(3-carboxy-5-pyridinyl)thiourea(CAS DataBase Reference)
• NIST Chemistry Reference: N-(benzoyl)-N'-(3-carboxy-5-pyridinyl)thiourea(247102-02-9)
• EPA Substance Registry System: N-(benzoyl)-N'-(3-carboxy-5-pyridinyl)thiourea(247102-02-9)

Safety Data

• Hazardous Substances Data: 247102-02-9(Hazardous Substances Data)

Upstream product

• 24242-19-1 5-aminonicotinic acid 
• 532-55-8 Benzoyl isothiocyanate 

Downstream Products

• 1541197-03-8 (S)-3-(3,5-di-tert-butylphenyl)-3-(2-(5-guanidinonicotinamido)acetamido)propanoic acid 
• 1541198-94-0 (S)-ethyl 3-(3,5-di-tert-butylphenyl)-3-(2-(5-guanidinonicotinamido)acetamido)propanoate 
• 1541196-98-8 (3S)-3-(3-bromo-5-(tert-butyl)phenyl)-3-(2-(5-((5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino)nicotinamido)acetamido)propanoic acid 
• 1541198-88-2 (3S)-ethyl 3-(3-bromo-5-(tert-butyl)phenyl)-3-(2-(5-((5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino)nicotinamido)acetamido)propanoate 
• 1541196-92-2 (S)-3-(3-bromo-5-(tert-butyl)phenyl)-3-(2-(5-guanidinonicotinamido)acetamido)propanoic acid 
• 1541198-85-9 (S)-ethyl 3-(3-bromo-5-(tert-butyl)phenyl)-3-(2-(5-guanidinonicotinamido)acetamido)propanoate 
• 247099-90-7 (3R)-3-(3-bromo-5-chloro-2-hydroxyphenyl)-3-{[N-({5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]pyridin-3-yl}carbonyl)glycyl]amino}-propanoic acid 
• 727417-38-1 C₂₁H₂₂BrClN₆O₆C₂H₄ 
• 726190-88-1 C₂₁H₂₁N₆O₅FCl₂C₂H₄ 

Relevant articles and documents

META-AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS PAN INTEGRIN ANTAGONISTS

The present disclosure provides pharmaceutical agents of the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such pharmaceutical agents. Methods of using the pharmaceutical agents for the treatment of a variety of diseases and disorders are also provided.

R-Isomers of Arg-Gly-Asp (RGD) mimics as potent αvβ3 inhibitors

The integrin αvβ3, vitronectin receptor, is expressed in a number of cell types and has been shown to mediate adhesion of osteoclasts to bone matrix, vascular smooth muscle cell migration, and angiogenesis. We recently disclosed the